Apr 23, 2025 / 07:00AM GMT
Operator
Welcome to Biotage Q1 2025 report presentation. (Operator Instructions)
Now I will hand the conference over to CEO and President, Frederic Vanderhaegen and CFO, Andrew Kellett. Please go ahead.
Frederic Vanderhaegen - Biotage AB - Chief Executive Officer & President
Thank you. Good morning, everyone. Welcome to our Q1 report. Thank you for your flexibility today, and to accommodate all time changes very recently. Today's call is about our Q1 release. We will not comment on the recent announcements made by KKR. We would encourage anyone who has a question to reach out to Tober Jorgensen, who is the Chairman of a subcommittee that will answer your questions onwards.
Let me talk about the Q1 results. As expected, our Q1 revenue was softer than the prior year, primarily due to the volatility within our bioprocessing, which we had previously commented upon. Our relatively large exposure to the plasma business has impacted our overall performance. However, we did see growth in our non-plasma revenue, and by pressing gross margin continue to
Q1 2025 Biotage AB Earnings Call Transcript
3 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers